Intranasal etripamil effective for conversion of paroxysmal supraventricular tachycardia
1. Median time to sinus conversion was 17.2 minutes in the etripamil group versus 53.5 minutes in the placebo group. 2. Twice as many patients in the etripamil group converted to sinus rhythm than placebo. Evidence Rating Level: 1 (Excellent) Study Rundown: Symptomatic supraventricular tachycardia (SVT) can cause severe distress to patients. Current management includes